发明名称 USE OF ITK INHIBITORS FOR THE TREATMENT OF CANCER
摘要 This invention relates generally to the use of ITK (IL-2 inducible T-cell kinase) inhibitors for the treatment of patients who have melanoma or other solid tumors. Applicants demonstrate that ITK lentiviral small hairpin RNA knockdowns and a small molecule inhibitor can each decrease the proliferation and migration of melanoma cell lines and a small molecule inhibitor can be used to inhibit the growth of melanomas in vivo.
申请公布号 US2016000788(A1) 申请公布日期 2016.01.07
申请号 US201314647354 申请日期 2013.11.26
申请人 The University of North Carolina at Chapel Hill 发明人 Thomas Nancy;Dorsey Kathleen;Edmiston Sharon;Groben Pamela;Carson Craig
分类号 A61K31/519;A61K31/4155;A61K31/4184;A61K31/4985;A61K31/426 主分类号 A61K31/519
代理机构 代理人
主权项 1. A method of inhibiting the growth of a solid tumor in a subject which comprises administering an effective amount of a selective interleukin-2 inducible T-cell kinase (ITK) inhibitor to the subject.
地址 Chapel Hill NC US
您可能感兴趣的专利